Investigating infections caused by antibiotic-resistant enterococci
VENOUS: A translational study of enterococcal bacteremia
This study is looking at how infections from hard-to-treat bacteria called vancomycin-resistant enterococci (VRE) affect people with weakened immune systems or other health problems, and it aims to find better ways to treat these infections to help patients feel better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10849696 on NIH RePORTER |
What this research studies
This research focuses on enterococcal bacteremia, particularly in patients with weakened immune systems or multiple health issues. It aims to understand the clinical impact of infections caused by vancomycin-resistant enterococci (VRE), which are difficult to treat due to their resistance to many antibiotics. The study will involve collecting clinical data to guide treatment options and improve outcomes for affected patients. By examining the effectiveness of existing antibiotics and exploring new treatment strategies, the research seeks to address a significant gap in managing these serious infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include immunocompromised individuals, such as those with hematological malignancies or solid organ transplant recipients, who are at high risk for VRE infections.
Not a fit: Patients who do not have significant comorbidities or are not immunocompromised may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols for patients suffering from severe infections caused by antibiotic-resistant enterococci.
How similar studies have performed: While there is limited research specifically on VRE infections, studies on antibiotic-resistant bacteria have shown promise in improving treatment outcomes through targeted approaches.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Arias, Cesar Augusto — Methodist Hospital Research Institute
- Study coordinator: Arias, Cesar Augusto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.